DCM
ALXN

Driehaus Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Driehaus Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-92,205
Closed -$16.9M – 524
2021
Q2 		$16.9M Buy
92,205
+4,500
+5% +$772K 0.22% 146
2021
Q1 		$13.4M Buy
+87,705
New +$13.6M 0.2% 158
2019
Q3 		– Sell
-1,565
Closed -$205K – 605
2019
Q2 		$205K Buy
+1,565
New +$202K 0.01% 452
2013
Q3 		– Sell
-26,576
Closed -$2.45M – 548
2013
Q2 		$2.45M Buy
+26,576
New +$2.56M 0.12% 235

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return